We are live on ! Find out more
CMPX icon

Compass Therapeutics
CMPX

55 hedge funds and large institutions have $401M invested in Compass Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 1

340% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 5

287% more capital invested

Capital invested by funds: $104M → $401M (+$298M)

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

45% more funds holding

Funds holding: 38 → 55 (+17)

3.47% less ownership

Funds ownership: 66.73% → 63.26% (-3.5%)

Holders
55
Holders Change
+17
Holders Change %
+44.74%
% of All Funds
0.88%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
19
Increased
22
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Blackstone Inc
Blackstone Inc
New York
+$12.4M
2
BBA
Baker Bros. Advisors
New York
+$6.21M
3
VC
Vivo Capital
California
+$6.21M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.9M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.66M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$4.41M
2
EAM
Eventide Asset Management
Massachusetts
-$659K
3
Marshall Wace
Marshall Wace
United Kingdom
-$93.8K
4
Renaissance Technologies
Renaissance Technologies
New York
-$49.1K
5
FHA
Flagship Harbor Advisors
Massachusetts
-$9.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$112M +$1.6M +402,000 +2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$32M – – –
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$29.8M -$4.41M -1,106,670 -16%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$29M +$4.66M +1,168,200 +25%
RSCM
5
Rock Springs Capital Management
Maryland
$26.8M – – –
Blackstone Inc
6
Blackstone Inc
New York
$23.2M +$12.4M +3,115,260 +207%
FCMV
7
Foresite Capital Management V
California
$22.1M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$18.2M +$4.9M +1,229,781 +52%
VC
9
Vivo Capital
California
$17.9M +$6.21M +1,557,630 +78%
CA
10
CHI Advisors
New York
$14.2M – – –
MIM
11
Monashee Investment Management
Massachusetts
$11.2M +$3.99M +1,000,000 +81%
APM
12
Avidity Partners Management
Texas
$10.1M – – –
B
13
Braidwell
Connecticut
$9.13M +$7.24M +1,814,266 New
BBA
14
Baker Bros. Advisors
New York
$7.83M +$6.21M +1,557,630 New
BlackRock
15
BlackRock
New York
$6.23M +$1.46M +365,284 +42%
EAM
16
Eventide Asset Management
Massachusetts
$4.7M -$659K -165,308 -15%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.97M +$754K +188,924 +31%
FAM
18
Fred Alger Management
New York
$3.06M – – –
DCM
19
DAFNA Capital Management
California
$3.03M +$1.65M +413,957 +220%
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$2.73M +$2.17M +545,170 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$2.29M +$1.74M +435,943 +2,209%
Hudson Bay Capital Management
22
Hudson Bay Capital Management
Connecticut
$1.49M +$1.24M +311,500 New
State Street
23
State Street
Massachusetts
$1.36M +$1.08M +270,113 New
SCM
24
Silverarc Capital Management
Massachusetts
$1.35M +$24.8K +6,217 +2%
CC
25
Caxton Corporation
New Jersey
$1.06M +$842K +211,159 New
1
2 3

CMPX Hedge Fund Activity: Q4 2022 in Review

55 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Compass Therapeutics (CMPX) for Q4 2022, worth a combined $401M — up 287% from $104M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CMPX positions and 1 closed out — a net gain of 18 holders — while 22 added to existing stakes and 5 trimmed.

The largest buyer was Blackstone Inc, adding an estimated $12.4M. The largest seller was Janus Henderson Group, cutting an estimated $4.41M.

  • 55 institutional investors held Compass Therapeutics (CMPX) as of Q4 2022, up from 38 in Q3 2022.
  • Funds reported $401M of Compass Therapeutics stock for Q4 2022, up 287% quarter-over-quarter.
  • 19 funds opened new Compass Therapeutics positions in Q4 2022 and 1 closed out, a net change of +18 holders.
  • The largest Compass Therapeutics buyer in Q4 2022 was Blackstone Inc, an estimated $12.4M added.
  • The largest Compass Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $4.41M sold.

Based on aggregated 13F filings for Q4 2022.